P005. Efficacy Type-A Botulinum toxin treatment in a multidisciplinary setting for chronic headache
نویسندگان
چکیده
منابع مشابه
Acupuncture and botulinum toxin A injection in the treatment of chronic migraine: A randomized controlled study
Background: Migraine is a common type of headache. Sometimes adequate pain relief is not achieved by conventional treatments. Acupuncture and botulinum toxin-A injection are known as non-pharmacological interventions for this purpose. The aim of this research was to compare the effect of acupuncture with botulinum toxin-A injection and pharmacological treatment in controlling chronic migraine. ...
متن کاملReview of botulinum toxin type A for the prophylactic treatment of chronic daily headache
Botulinum toxin A is increasingly used in the treatment of idiopathic and symptomatic headache disorders. However, only few controlled trials are available and many trials can hardly be compared to each other because of different endpoints and different trial designs. In particular chronic daily headache, which is defined as an idiopathic headache occurring on more than 15 days per month for at...
متن کاملBotulinum Toxin Type A on an Intranasal Sponge for Chronic Allergic Rhinitis: Randomized Clinical Trial
Objectives: In this study, we examined the effect of botulinum toxin A (BTA) on chronic allergic rhinitis (CAR). We tested the effects of BTA, applied to an intranasal sponge, on patients who had CAR for a minimum of three years and had been treated unsuccessfully with conventional medications. Methods:The study was an interventional case-control single-blind randomized clinical trial. Forty...
متن کاملBotulinum toxin for treatment of primary chronic headache disorders.
Migraine. Since the 2002 TEC Assessment, 1 new study meeting selection criteria has appeared. Published in 2004 (n=60), this trial randomized patients to saline placebo, low-dose BTX-A, or high-dose BTX-A. No significant differences were reported at 3 months for any of 7 pain-related outcomes. The low dose of BTX-A had a lower rate of accompanying symptoms (photophobia, phonophobia, nausea and ...
متن کاملefficacy of botulinum toxin type a for treating chronic low back pain
conclusions bont-a improves clbp with a low incidence of side effects and can be used as a therapeutic tool in the management of these patients. results after 4 weeks, 76% of patients in the bont-a group reported pain relief compared to 20% in the saline group (p < 0. 005). additionally, greater pain relief was experienced by patients in the bont-a group at 8 weeks (64% vs. 12%; p < 0. 001). by...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Headache and Pain
سال: 2015
ISSN: 1129-2369,1129-2377
DOI: 10.1186/1129-2377-16-s1-a185